Cargando…

Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance

Targeted agents have improved the efficacy of chemotherapy for cancer patients, however, there remains a lack of understanding of how these therapies affect the unsuspecting bystanders of the stromal microenvironment. Cetuximab, a monoclonal antibody therapy targeting the epidermal growth factor rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garvey, Colleen M., Lau, Roy, Sanchez, Alyssa, Sun, Ren X., Fong, Emma J., Doche, Michael E., Chen, Oscar, Jusuf, Anthony, Lenz, Heinz-Josef, Larson, Brent, Mumenthaler, Shannon M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352975/ https://www.ncbi.nlm.nih.gov/pubmed/32481658 http://dx.doi.org/10.3390/cancers12061393

Ejemplares similares

Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer
por: Ghate, Nikhil B., et al.
Publicado: (2023)

RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer
por: Di Donato, Marzia, et al.
Publicado: (2023)

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques
por: Garvey, Colleen M., et al.
Publicado: (2017)

Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation
por: Venè, Roberta, et al.
Publicado: (2015)

Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
por: Lindsay, Danika, et al.
Publicado: (2016)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
por: Ireland, Lucy V., et al.
Publicado: (2018)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling
por: Su, Liangping, et al.
Publicado: (2023)

PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells
por: Jiang, Lu, et al.
Publicado: (2013)

Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways
por: Tito, Claudia, et al.
Publicado: (2023)

CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells
por: Deng, Wenjie, et al.
Publicado: (2016)

A Perspective on Expanding Our Understanding of Cancer Treatments by Integrating Approaches from the Biological and Physical Sciences
por: Fong, Emma J., et al.
Publicado: (2020)

EGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal Therapy
por: Silva, Catarina Oliveira, et al.
Publicado: (2016)

Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
por: Strelez, Carly, et al.
Publicado: (2021)

VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
por: Ghate, Nikhil Baban, et al.
Publicado: (2021)

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation
por: Yao, Wenfang, et al.
Publicado: (2012)

High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR
por: Han, Liang, et al.
Publicado: (2011)

Relationship between EGF, TGFA, and EGFR Gene Polymorphisms and Traditional Chinese Medicine ZHENG in Gastric Cancer
por: Zhang, Junfeng, et al.
Publicado: (2013)

The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway
por: Ye, Junhong, et al.
Publicado: (2023)

The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
por: Huang, Peixin, et al.
Publicado: (2014)

Folliculin Interacts with Rab35 to Regulate EGF-Induced EGFR Degradation
por: Zheng, Jianchao, et al.
Publicado: (2017)

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
por: Sueangoen, Natthaporn, et al.
Publicado: (2020)

Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor
por: Liu, Ning Sheng, et al.
Publicado: (2009)

mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer
por: Chiang, Chun-Te, et al.
Publicado: (2018)

Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer
por: Hu, Yibing, et al.
Publicado: (2015)

Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway
por: Lian, Guanghui, et al.
Publicado: (2019)

Critical roles for EGFR and EGFR–HER2 clusters in EGF binding of SW620 human carcinoma cells
por: Wollman, Adam J. M., et al.
Publicado: (2022)

Multiplexed imaging and effluent analysis to monitor cancer cell intravasation using a colorectal cancer-on-chip
por: Strelez, Carly, et al.
Publicado: (2021)

SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR
por: Thomas, J. Terrig, et al.
Publicado: (2016)

Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium
por: Duan, Chen, et al.
Publicado: (2016)

Deficiency of GABARAP but Not Its Paralogs Causes Enhanced EGF-Induced EGFR Degradation
por: Dobner, Jochen, et al.
Publicado: (2020)

USP25 Regulates EGFR Fate by Modulating EGF-Induced Ubiquitylation Dynamics
por: Niño, Carlos A., et al.
Publicado: (2020)

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
por: Koh, Siang-Boon, et al.
Publicado: (2021)

A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer
por: Cao, Tianyu, et al.
Publicado: (2022)

Integration of Patient-Derived Organoids and Organ-on-Chip Systems: Investigating Colorectal Cancer Invasion within the Mechanical and GABAergic Tumor Microenvironment
por: Strelez, Carly, et al.
Publicado: (2023)

Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
por: He, Qing, et al.
Publicado: (2016)

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer
por: Song, Lei, et al.
Publicado: (2016)

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017)

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer
por: Xu, Cong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o1ur090rq53p80odqdk21glfdu